181 related articles for article (PubMed ID: 29182323)
1. Demystifying P2Y
Ciancetta A; O'Connor RD; Paoletta S; Jacobson KA
J Chem Inf Model; 2017 Dec; 57(12):3104-3123. PubMed ID: 29182323
[TBL] [Abstract][Full Text] [Related]
2. Two disparate ligand-binding sites in the human P2Y1 receptor.
Zhang D; Gao ZG; Zhang K; Kiselev E; Crane S; Wang J; Paoletta S; Yi C; Ma L; Zhang W; Han GW; Liu H; Cherezov V; Katritch V; Jiang H; Stevens RC; Jacobson KA; Zhao Q; Wu B
Nature; 2015 Apr; 520(7547):317-21. PubMed ID: 25822790
[TBL] [Abstract][Full Text] [Related]
3. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information.
Paoletta S; Sabbadin D; von Kügelgen I; Hinz S; Katritch V; Hoffmann K; Abdelrahman A; Straßburger J; Baqi Y; Zhao Q; Stevens RC; Moro S; Müller CE; Jacobson KA
J Comput Aided Mol Des; 2015 Aug; 29(8):737-56. PubMed ID: 26194851
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent.
Le HTT; Rimpilainen T; Konda Mani S; Murugesan A; Yli-Harja O; Candeias NR; Kandhavelu M
Sci Rep; 2019 Dec; 9(1):18938. PubMed ID: 31831761
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Different Agonist-Binding Site and Activation Mechanism of the Human P2Y
Li Y; Yin C; Liu P; Li D; Lin J
Sci Rep; 2017 Oct; 7(1):13764. PubMed ID: 29062134
[TBL] [Abstract][Full Text] [Related]
6. BPTU, an allosteric antagonist of P2Y1 receptor, blocks nerve mediated inhibitory neuromuscular responses in the gastrointestinal tract of rodents.
Mañé N; Jiménez-Sábado V; Jiménez M
Neuropharmacology; 2016 Nov; 110(Pt A):376-385. PubMed ID: 27496690
[TBL] [Abstract][Full Text] [Related]
7. Distinct Signaling Patterns of Allosteric Antagonism at the P2Y
Gao ZG; Jacobson KA
Mol Pharmacol; 2017 Nov; 92(5):613-626. PubMed ID: 28864555
[TBL] [Abstract][Full Text] [Related]
8. The Molecular Mechanism of P2Y1 Receptor Activation.
Yuan S; Chan HC; Vogel H; Filipek S; Stevens RC; Palczewski K
Angew Chem Int Ed Engl; 2016 Aug; 55(35):10331-5. PubMed ID: 27460867
[TBL] [Abstract][Full Text] [Related]
9. Molecular interaction of HIC, an agonist of P2Y1 receptor, and its role in prostate cancer apoptosis.
Le HTT; Murugesan A; Ramesh T; Yli-Harja O; Konda Mani S; Kandhavelu M
Int J Biol Macromol; 2021 Oct; 189():142-150. PubMed ID: 34425116
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of 2-(phenoxyaryl)-3-urea derivatives as novel P2Y
Peng J; Zhao L; Wang L; Chen H; Qiu Y; Wang J; Yang H; Liu J; Liu H
Eur J Med Chem; 2018 Oct; 158():302-310. PubMed ID: 30223118
[TBL] [Abstract][Full Text] [Related]
11. Functional interaction between purinergic receptors: effect of ligands for A2A and P2Y12 receptors on P2Y1 receptor function.
Suzuki T; Obara Y; Moriya T; Nakata H; Nakahata N
FEBS Lett; 2011 Dec; 585(24):3978-84. PubMed ID: 22079667
[TBL] [Abstract][Full Text] [Related]
12. New azole antagonists with high affinity for the P2Y(1) receptor.
Ruel R; L'Heureux A; Thibeault C; Daris JP; Martel A; Price LA; Wu Q; Hua J; Wexler RR; Rehfuss R; Lam PY
Bioorg Med Chem Lett; 2013 Jun; 23(12):3519-22. PubMed ID: 23668989
[TBL] [Abstract][Full Text] [Related]
13. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of action for reversible P2Y12 antagonists.
Liu H; Ge H; Peng Y; Xiao P; Xu J
Biophys Chem; 2011 May; 155(2-3):74-81. PubMed ID: 21440362
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
16. Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs.
Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Lee JH
Neuropharmacology; 2014 Apr; 79():368-79. PubMed ID: 24333674
[TBL] [Abstract][Full Text] [Related]
17. Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y
Rafehi M; Neumann A; Baqi Y; Malik EM; Wiese M; Namasivayam V; Müller CE
J Med Chem; 2017 Oct; 60(20):8425-8440. PubMed ID: 28938069
[TBL] [Abstract][Full Text] [Related]
18. Potent P2Y1 urea antagonists bearing various cyclic amine scaffolds.
Ruel R; L'Heureux A; Thibeault C; Lapointe P; Martel A; Qiao JX; Hua J; Price LA; Wu Q; Chang M; Zheng J; Huang CS; Wexler RR; Rehfuss R; Lam PY
Bioorg Med Chem Lett; 2013 Dec; 23(24):6825-8. PubMed ID: 24269480
[TBL] [Abstract][Full Text] [Related]
19. Different responses of the blockade of the P2Y1 receptor with BPTU in human and porcine intestinal tissues and in cell cultures.
Traserra S; Barber C; Maclnnes J; Relea L; MacPherson LC; Cunningham MR; Vergara P; Accarino A; Kennedy C; Jimenez M
Neurogastroenterol Motil; 2021 Jul; 33(7):e14101. PubMed ID: 33619847
[TBL] [Abstract][Full Text] [Related]
20. 2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agents.
Pi Z; Sutton J; Lloyd J; Hua J; Price L; Wu Q; Chang M; Zheng J; Rehfuss R; Huang CS; Wexler RR; Lam PY
Bioorg Med Chem Lett; 2013 Jul; 23(14):4206-9. PubMed ID: 23743287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
